| Field | Specification |
|---|---|
| Target | |
| Alternative names | Serine/threonine-protein kinase mTOR;2.7.11.1;FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;mTOR;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;MTOR;FRAP, FRAP1, FRAP2, RAFT1, RAPT1; |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthesized peptide derived from human mTOR |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Liquid |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Clone CBD-13 is a rabbit monoclonal antibody that recognizes serine/threonine-protein kinase mTOR in human, mouse and rat samples and is validated for Western blot, IHC, ICC/IF, immunoprecipitation and flow cytometry. The predicted molecular weight is 288.9 kDa, and the supplier reports an observed band at about 289 kDa.
mTOR is a serine/threonine kinase that forms two complexes, mTORC1 and mTORC2, and serves as a central integrator of nutrient, growth factor and energy signals. mTORC1 drives protein, lipid and nucleotide synthesis through targets such as S6K and 4E-BP1 and suppresses autophagy. mTOR signaling is studied across cell growth, metabolism, aging, immunity and cancer.
| Target | Serine/threonine-protein kinase mTOR (gene MTOR; UniProt P42345, human) |
|---|---|
| Clone | CBD-13 |
| Host / Clonality / Isotype | Rabbit / Monoclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Liquid |
| Formulation | PBS (pH 7.4); 150 mM NaCl; 0.02% sodium azide; 50% glycerol; plus stabilizers |
| Calculated MW | 288.9 kDa |
| Observed MW | 289 kDa |
| Storage | Long term: −20 °C for up to 12 months. Frequent use: 4 °C for up to 1 month. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 1:500–1:2000 |
|---|---|
| Immunohistochemistry | 1:50–1:200 |
| Immunocytochemistry / Immunofluorescence | 1:50–1:200 |
| Immunoprecipitation | 1:30 |
| Flow cytometry | 1:20 |
Samples with a confirmed band (WB): human 293T cells, human HeLa cells, human K562 cells, rat brain tissue, rat C6 cells, mouse brain tissue, mouse Neuro-2a cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 1:500 overnight at 4 °C, HRP-conjugated secondary antibody at 1:500, ECL detection.
Samples with confirmed staining (IHC): rat liver tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Immunogen
Synthetic peptide based on the sequence of human mTOR.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. UniProt places serine/threonine-protein kinase mTOR in the lysosome membrane, endoplasmic reticulum membrane and Golgi apparatus membrane. Tissue expression noted by UniProt (human): Expressed in numerous tissues, with highest levels in testis. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Tingkui Zhao et al. (2023) A Triple-Targeted Rutin-Based Self-Assembled Delivery Vector for Treating Ischemic Stroke by Vascular Normalization and Anti-Inflammation via ACE2/Ang1-7 Signaling. ACS Central Science. 10.1021/acscentsci.3c00377
Xue Li et al. (2025) Gymconopin C exhibits anti-non-small cell lung cancer effect by regulating miR-6777-5p/ADRB2 pathway to promote mitophagy. Journal of Advanced Research. 10.1016/j.jare.2025.12.023
Juan Cen et al. (2022) A Water-Soluble Quercetin Conjugate with Triple Targeting Exerts Neuron-Protective Effect on Cerebral Ischemia by Mitophagy Activation. Advanced Healthcare Materials. 10.1002/adhm.202200817
Yue Peng et al. (2026) Rational design of curcumin-borneol hybrids for rheumatoid arthritis pathological intervention via AKT/mTOR/HIF-1α pathway modulation. Materials & Design. 10.1016/j.matdes.2026.116214
Qihui Luo et al. (2022) Polyphyllin I Promotes Autophagic Cell Death and Apoptosis of Colon Cancer Cells via the ROS-Inhibited AKT/mTOR Pathway. International Journal of Molecular Sciences. 10.3390/ijms23169368
Yang Jing-jing et al. (2026) Silencing Uracil-DNA glycosylase inhibits colorectal cancer progression. Cancer Cell International. 10.1186/s12935-025-04089-y
Yongya Wu et al. (2020) Effect and mechanism of PI3K/AKT/mTOR signaling pathway in the apoptosis of GC-1 cells induced by nickel nanoparticles. Chemosphere. 10.1016/j.chemosphere.2020.126913
Chen Guo et al. (2026) BEZ235 enhances the photodynamic antitumor efficacy of hypoxia-responsive BODIPY prodrug nanoparticles by inhibiting the PI3K/mTOR pathway and alleviating hypoxia. Colloids and Surfaces B-Biointerfaces. 10.1016/j.colsurfb.2026.115644
Xiaorui Liu et al. (2020) miR-34a/c induce caprine endometrial epithelial cell apoptosis by regulating circ-8073/CEP55 via the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR pathways. Journal of Cellular Physiology. 10.1002/jcp.29821
Li Ma et al. (2022) Effect of MiR-100-5p on proliferation and apoptosis of goat endometrial stromal cell in vitro and embryo implantation in vivo. Journal of Cellular and Molecular Medicine. 10.1111/jcmm.17226
